Back ground: There is a strong positive significant correlation between grades of papilledema by optical coherence tomography and grades of papilledema by modified Frisen scale Aim of the work: is to identify and correlate the role of the coherent optical tomography imaging of the head of the optic nerve with the clinical grading of papilledema using frisen scale via digital fundus photographs. Patient and methods: It is a randomized study in which 40 eyes of 20 patients were selected for the study from the patients attending in the outpatient neurology and ophthalmology clinics of Al Azhar University Hospitals in Cairo between August 2021 and July 2022. Results: The current study showed that the papilledema was distributed according to optical coherence tomography into 10 (25%) stage 1, 26(65%) stage 2, and 4(10%) stage 3. The papilledema was distributed according to modified Frisen scale into 10(25%) stage 1, 22(55%) stage 2, 4(10%) stage 3, and 4(10%) stage 4. There was highly significant association and correlation between grades of papilledema by optical coherence tomography and grades of papilledema by modified Frisen scale (p
Lasheen, A. M. Z., Almasry, M. A., & Mostafa, M. M. (2644). Assessment and grading of papilledema using optical Coherence Tomography. Al-Azhar International Medical Journal, 2023(1), -. doi: 10.58675/2682-339X.1626
MLA
Ahmed Mohammed Zaki Lasheen; Moahammed Anwar Almasry; Mostafa Mahmoud Mostafa. "Assessment and grading of papilledema using optical Coherence Tomography", Al-Azhar International Medical Journal, 2023, 1, 2644, -. doi: 10.58675/2682-339X.1626
HARVARD
Lasheen, A. M. Z., Almasry, M. A., Mostafa, M. M. (2644). 'Assessment and grading of papilledema using optical Coherence Tomography', Al-Azhar International Medical Journal, 2023(1), pp. -. doi: 10.58675/2682-339X.1626
VANCOUVER
Lasheen, A. M. Z., Almasry, M. A., Mostafa, M. M. Assessment and grading of papilledema using optical Coherence Tomography. Al-Azhar International Medical Journal, 2644; 2023(1): -. doi: 10.58675/2682-339X.1626